Acute hepatitis B with delta-agent
ICD-10 B17 is a billable code used to indicate a diagnosis of acute hepatitis b with delta-agent.
Acute hepatitis B with delta-agent is a viral infection caused by the hepatitis B virus (HBV) in conjunction with the hepatitis D virus (HDV). This condition is characterized by the presence of both viruses, which can lead to more severe liver disease than hepatitis B alone. The delta agent requires the presence of HBV to replicate, making co-infection a significant concern. Acute hepatitis B typically presents with symptoms such as jaundice, fatigue, abdominal pain, and elevated liver enzymes. Transmission occurs primarily through contact with infectious body fluids, including blood, semen, and vaginal secretions. High-risk populations include individuals with multiple sexual partners, intravenous drug users, and healthcare workers. Chronic management of patients with acute hepatitis B with delta-agent focuses on monitoring liver function, managing symptoms, and preventing complications such as cirrhosis and hepatocellular carcinoma. Early diagnosis and intervention are crucial to mitigate the risk of progression to chronic liver disease.
Detailed serological test results and clinical findings.
Diagnosis and management of acute hepatitis B with delta-agent in high-risk populations.
Ensure documentation reflects the acute nature and co-infection status.
Liver function tests, imaging studies, and treatment plans.
Management of liver complications arising from acute hepatitis B with delta-agent.
Document any liver biopsy results or treatment interventions.
Used to confirm the diagnosis of acute hepatitis B.
Document the reason for testing and results.
Infectious disease specialists should ensure comprehensive testing for both HBV and HDV.
The delta-agent (HDV) can worsen the severity of hepatitis B infection and increase the risk of liver complications, making it crucial to identify in patients.
